Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?

by Di Molfetta, Sergio, Dotto, Andrea, Fanciulli, Giuseppe, Florio, Tullio, Feola, Tiziana, Colao, Annamaria, Faggiano, Antongiulio
Published in Front Endocrinol (Lausanne) (2021)

Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management

by Fanciulli, Giuseppe, Di Molfetta, Sergio, Dotto, Andrea, Florio, Tullio, Feola, Tiziana, Colao, Annamaria, Faggiano, Antongiulio
Published in Front Endocrinol (Lausanne) (2021)

Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis

by Castellana, Marco, Parisi, Claudia, Di Molfetta, Sergio, Di Gioia, Ludovico, Natalicchio, Annalisa, Perrini, Sebastio, Cignarelli, Angelo, Laviola, Luigi, Giorgino, Francesco
Published in BMJ Open Diabetes Res Care (2020)

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks

by Fanciulli, Giuseppe, Di Molfetta, Sergio, Dotto, Andrea, Florio, Tullio, Feola, Tiziana, Rubino, Manila, de Cicco, Federica, Colao, Annamaria, Faggiano, Antongiulio
Published in J Clin Med (2020)

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes

by Irace, Concetta, Cutruzzolà, Antonio, Nuzzi, Annamaria, Assaloni, Roberta, Brunato, Barbara, Pitocco, Dario, Tartaglione, Linda, Di Molfetta, Sergio, Cignarelli, Angelo, Laviola, Luigi, Citro, Giuseppe, Lovati, Elisabetta, Gnasso, Agostino, Tweden, Katherine S, Kaufman, Francine R
Published in Diabetes Obes Metab (2020)